A phase IIA study of tisotumab vedotin (Humax - TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer

التفاصيل البيبلوغرافية
العنوان: A phase IIA study of tisotumab vedotin (Humax - TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer
المؤلفون: Vergote, I, Concin, N, Dean, E, Lassen, U, De Bono, JS, Drew, Y, Machiels, JP, Nielsen, D, Arkenau, T, Forster, M, Jones, R, Slomovitz, B, Spicer, J, Johnson, M, Cornez, N, GENNIGENS, Christine, Fulton, B, Basse, L, Lisby, S, Coleman, R, Hong, DS
المصدر: A phase IIA study of tisotumab vedotin (Humax - TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer. Annals of Oncology, 28(suppl 5), 331.London, United KingdomOxford University Press. (2017).
سنة النشر: 2017
مصطلحات موضوعية: oncology, metastatic cervical cancer, Human health sciences :: Oncology, Sciences de la santé humaine :: Oncologie
نوع الوثيقة: conferenceObject
اللغة: English
Relation: ESMO Congress, Madrid, Spain (08 - 12 September 2017)
URL الوصول: https://orbi.uliege.be/handle/2268/220956
حقوق: info:eu-repo/semantics/restrictedAccess
رقم الأكسشن: edsorb.220956
قاعدة البيانات: ORBi